FdaApplication

ANDA 215440

Back to search

Identifiers

Properties

PropertyValue
applicant_nameZYDUS PHARMACEUTICALS USA INC
application_typeANDA
approval_date2023-08-31

Products (2)

ProductActive ingredientStrengthDosage form
ERYTHROMYCINERYTHROMYCIN250MGTABLET;ORAL
ERYTHROMYCINERYTHROMYCIN500MGTABLET;ORAL

2 products